R2 Addendum- Changes Impacting Sponsors-CRO-Sites

When: Tue., Nov. 6, 10-11 a.m. 2018

Overview: The revised guidelines are entitled "Integrated Addendum To ICH E6(R1): Guideline For Good Clinical Practice E6(R2)." The ICH steering committee comprised of representatives from the pharmaceutical industry and the regulatory bodies of the United States, Japan, the European Union (EU), Canada, and Switzerland. Why should you Attend: In this webinar we will identify the changes impacting investigators, sites, Sponsors, CROs: responsibilities and roles and explain the impact of the revisions on clinical trials conduct and organizational practices.

Price: 150

Buy Tickets


Add a review


Select a star to rate.